Innate Pharma S.A.
IPHANASDAQHealthcare● Active
$1.76
+$0.05(+2.92%)
Market Cap$165269787
P/E Ratio—
52W High$2.63
52W Low$1.17
Innate Pharma S.A. (IPHA) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · IPHA · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $34.30M | $80.77M | $92.46M | $101.48M | $119.84M |
| Net Receivables | $12.39M | $1.64M | $46.49M | $3.14M | $1.66M |
| Inventory | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Current Assets | $46.69M | $85.74M | $148.01M | $139.83M | $138.26M |
| PP&E Net | $4.35M | $5.13M | $6.32M | $8.54M | $10.17M |
| Goodwill | $0.00M | $0.00M | $0.00M | ($41.00M) | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.42M | $42.55M | $44.19M |
| Total Assets | $62.69M | $111.06M | $175.19M | $207.86M | $267.50M |
| Liabilities | |||||
| Short-Term Debt | $8.80M | $8.44M | $8.45M | $1.26M | $29.94M |
| Accounts Payable | $15.04M | $7.92M | $8.56M | $13.66M | $14.73M |
| Total Current Liabilities | $36.63M | $32.98M | $39.64M | $41.34M | $79.89M |
| Long-Term Debt | $13.77M | $22.18M | $30.61M | $38.93M | $11.49M |
| Total Liabilities | $84.39M | $102.22M | $132.29M | $153.71M | $160.06M |
| Stockholders Equity | |||||
| Retained Earnings | ($435.36M) | ($386.36M) | ($336.89M) | ($330.32M) | ($272.21M) |
| Total Stockholders Equity | ($21.69M) | $8.83M | $51.90M | $54.15M | $107.44M |
| Total Liab & Equity(computed) | $62.69M | $111.06M | $184.19M | $207.86M | $267.50M |
| Debt Summary | |||||
| Total Debt | $22.56M | $31.00M | $39.89M | $42.25M | $44.25M |
| Net Debt | ($5.52M) | ($35.40M) | ($30.71M) | ($41.97M) | ($59.51M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · EUR · M
Explore more Innate Pharma S.A. data
About Innate Pharma S.A. (IPHA) Balance Sheet
Innate Pharma S.A. (IPHA) balance sheet shows total assets of $0.06B with cash of $0.03B. Total liabilities are $0.08B, total debt $0.02B, and stockholders equity ($0.02B).
Frequently asked questions
IPHA · 4 questionsInnate Pharma S.A. has total debt of $0.02B with net debt of ($0.01B).
IPHA total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10